Lack of methadone dose alterations or withdrawal symptoms during therapy with lopinavir/ritonavir.

Suppr

超能文献

作者信息

Stevens Robert C, Rapaport Steven, Maroldo-Connelly Laura, Patterson James B, Bertz Richard

出版信息

J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):650-1. doi: 10.1097/00126334-200308150-00016.

DOI:10.1097/00126334-200308150-00016

PMID:12902812

Abstract

摘要

相似文献

Lack of methadone dose alterations or withdrawal symptoms during therapy with lopinavir/ritonavir.

J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):650-1. doi: 10.1097/00126334-200308150-00016.

The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients.

Clin Infect Dis. 2003 Aug 15;37(4):476-82. doi: 10.1086/376907. Epub 2003 Aug 1.

Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavir.

Clin Infect Dis. 2002 Apr 15;34(8):1143-5. doi: 10.1086/339541. Epub 2002 Mar 19.

Methadone dosing in patients on ritonavir-boosted-based highly active antiretroviral therapy.

Med Clin (Barc). 2019 Feb 15;152(4):161-162. doi: 10.1016/j.medcli.2018.03.004. Epub 2018 Apr 21.

Drug interaction between amprenavir and lopinavir/ritonavir in salvage therapy.

AIDS. 2002 Mar 29;16(5):797-8. doi: 10.1097/00002030-200203290-00018.

The effect of acid reduction with a proton pump inhibitor on the pharmacokinetics of lopinavir or ritonavir in HIV-infected patients on lopinavir/ritonavir-based therapy.

J Clin Pharmacol. 2010 Sep;50(9):1050-5. doi: 10.1177/0091270009357431. Epub 2010 Feb 10.

[Kaletra (lopinavir/ritonavir--a new HIV protease inhibitor].

Antibiot Khimioter. 2002;47(11):27-9.

[Lopinavir/ritonavir monotherapy in the treatment of HIV infection. Introduction].

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 16:1. doi: 10.1016/s0213-005x(08)76602-3.

Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression.

J Acquir Immune Defic Syndr. 2006 Apr 1;41(4):531-2. doi: 10.1097/01.qai.0000209902.89878.c9.

Lopinavir/ritonavir.

J Assoc Nurses AIDS Care. 2001 Mar-Apr;12(2):101-4. doi: 10.1016/S1055-3290(06)60137-4.

引用本文的文献

Finding what works: identification of implementation strategies for the integration of methadone maintenance therapy and HIV services in Vietnam.

Implement Sci. 2016 Apr 20;11:54. doi: 10.1186/s13012-016-0420-8.

An Engineered Endomorphin-2 Gene for Morphine Withdrawal Syndrome.

PLoS One. 2016 Mar 22;11(3):e0149877. doi: 10.1371/journal.pone.0149877. eCollection 2016.

Cytochrome P4503A does not mediate the interaction between methadone and ritonavir-lopinavir.

Drug Metab Dispos. 2013 Dec;41(12):2166-74. doi: 10.1124/dmd.113.053991. Epub 2013 Sep 25.

A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice.

Expert Rev Clin Pharmacol. 2013 May;6(3):249-69. doi: 10.1586/ecp.13.18.

Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users.

Subst Use Misuse. 2011;46(2-3):218-32. doi: 10.3109/10826084.2011.522840.

Mechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: I. Evidence against CYP3A mediation of methadone clearance.

Clin Pharmacol Ther. 2008 Oct;84(4):497-505. doi: 10.1038/clpt.2008.104.

Practical considerations for the clinical use of buprenorphine.

Sci Pract Perspect. 2004 Aug;2(2):4-20. doi: 10.1151/spp04224.

Treatment of opioid-dependent pregnant women: clinical and research issues.

J Subst Abuse Treat. 2008 Oct;35(3):245-59. doi: 10.1016/j.jsat.2007.10.007. Epub 2008 Jan 14.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Drugs. 2006;66(9):1275-99. doi: 10.2165/00003495-200666090-00012.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验